INS and Glucose intolerance: When we examined the potential of AMY to ameliorate HFD-induced glucose intolerance and insulin insensitivity, the respective GTT and ITT results showed improvement of HFD-induced insulin resistance, evidenced by a decrease in the HOMA-IR index.